Nidogen-1: a candidate biomarker for ovarian serous cancer

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The ovarian cancer-derived secretory/releasing proteome: A repertoire of tumor markers

(2012) Ying Zhang et al.   PROTEOMICS

Clinical significance of decreased nidogen-2 expression in the tumor tissue and serum of patients with hepatocellular carcinoma

(2011) Zhi-Xiang Cheng et al.   JOURNAL OF SURGICAL ONCOLOGY

Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures

(2009) Chiara Braconi et al.   CANCER

Nidogen-2: A new serum biomarker for ovarian cancer

(2009) Cynthia Kuk et al.   CLINICAL BIOCHEMISTRY

Current status of gynecological cancer in China

(2009) Kidong Kim et al.   Journal of Gynecologic Oncology

The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial

(2008) Christine C. Johnson et al.   GYNECOLOGIC ONCOLOGY

Nidogens—Extracellular matrix linker molecules

(2008) Matthew S.P. HO et al.   MICROSCOPY RESEARCH AND TECHNIQUE